Optiver Holding
GILD icon

Optiver Holding’s Gilead Sciences GILD Stock Holding History

Optiver Holding’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,168
Closed -$601K – 1096
2024
Q3 		$601K Buy
+7,168
New +$547K ﹤0.01% 395
2024
Q1 		– Sell
-25
Closed -$2.02K – 705
2023
Q4 		$2.02K Buy
25
+20
+400% +$1.56K ﹤0.01% 473
2023
Q3 		$375 Buy
+5
New +$385 ﹤0.01% 541
2022
Q2 		– Sell
-68
Closed -$4K – 419
2022
Q1 		$4K Sell
68
-134
-66% -$8.57K ﹤0.01% 475
2021
Q4 		$14K Buy
202
+47
+30% +$3.24K ﹤0.01% 651
2021
Q3 		$11K Sell
155
-187
-55% -$13.1K ﹤0.01% 560
2021
Q2 		$24K Buy
+342
New +$22.8K ﹤0.01% 347

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Optiver Holding's GILD Position: Q4 2024 in Review

Optiver Holding sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 7,168 shares — an estimated $601K sold.

Optiver Holding first reported a position in GILD in Q2 2021 and held it in 7 quarters. The position peaked at $601K in Q3 2024. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Optiver Holding reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Optiver Holding sold 7,168 Gilead Sciences shares in Q4 2024, an estimated $601K.
  • Optiver Holding first reported a position in Gilead Sciences in Q2 2021 and held it in 7 quarters.
  • Optiver Holding's Gilead Sciences position peaked at $601K in Q3 2024.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Optiver Holding's 13F filing for Q4 2024, filed 14 Feb 2025.